About: Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

clinical trial

Attributes	Values
rdf:type	Item
description	clinical trial (en) ensayu clínicu (ast) klinisch onderzoek (nl) клінічне випробування (uk)
rdfs:label	Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure (en)
skos:prefLabel	Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure (en)
name	Dose-Escalation Study of CG0070 for Bladder Cancer After BCG (Bacillus Calmette-Guerin) Failure (en)
title	wds:Q62105340-84C6B9DF-80CF-4288-A014-0FFEF9D68FFC
title	A Phase 1 Dose-Escalation Trial of Intravesical CG0070 for Superficial Transitional Cell Carcinoma of the Bladder After Bacillus Calmette-Guerin Failure (en)
end time	wds:Q62105340-6B1C78D0-44BE-4180-B7FF-FCD5AC2ABDF5
end time	2008-10-01 00:00:00Z (xsd:dateTime)
instance of	wds:Q62105340-05E8F403-7112-498E-84ED-52EBAB341805
instance of	clinical trial
start time	wds:Q62105340-128FE2A6-9526-405F-9311-604432CC3904
start time	2005-04-01 00:00:00Z (xsd:dateTime)
country	wds:Q62105340-02DB7B14-526D-4582-B15C-0922BB4D5663 wds:Q62105340-243F4ED5-B7D8-4541-8BC2-DE96BFCBAF39
country	Malawi United States of America
main subject	wds:Q62105340-F3066A67-325A-4E89-97D1-B5A64D5BD3D5
main subject	superficial urinary bladder cancer
research site	wds:Q62105340-3A685D2B-8113-4139-95E9-7880BEA0C86B wds:Q62105340-9ED6B928-EDD3-4912-905F-4ED7B2F7BD07 wds:Q62105340-A6C3651F-4A4C-491E-A154-B5A54D47EA1A
research site	Columbia University Baylor College of Medicine Billings Clinic Cody
research intervention	wds:Q62105340-EFDA3E54-01BE-410D-8E3A-B40D68C84042
research intervention	BCG vaccine
minimum age	wds:Q62105340-37EE830B-3E0D-4C68-96F7-77CAC3398A26
minimum age	18 (xsd:decimal)
medical condition	wds:Q62105340-B3EAD068-BACC-480D-B811-2A6AAF37F44E
medical condition	carcinoma
number of participants	wds:Q62105340-E54C9AB5-012F-43C2-9913-5B5E209296DF
number of participants	75 (xsd:decimal)
study type	wds:Q62105340-DC856831-5FE3-40D8-9AE7-5D49B4BCEDCC
study type	interventional study
ClinicalTrials.gov ID	wds:Q62105340-9916C788-B72E-44A2-AC4D-863656988710
ClinicalTrials.gov ID	NCT00109655
clinical trial phase	wds:Q62105340-29C11E1B-B30B-4EFB-B4BF-FCFBEFD7CD42
clinical trial phase	phase I clinical trial
research subject recruitment status	wds:Q62105340-E9FB28AD-3151-4FD8-8A01-668943D8654A
research subject recruitment status	unknown
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q62105340

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 195 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software